Literature DB >> 16446717

Prognosticators of melanoma, the melanoma report, and the sentinel lymph node.

A Neil Crowson1, Cynthia M Magro, Martin C Mihm.   

Abstract

Since the 1960s, the clinical characteristics of melanoma, its histopathology and its biological basis have been the subject of intense study at pigmented lesion clinics in North America, Europe, and Australia. More recently, the immense database of the Melanoma Committee of the American Joint Committee on Cancer (AJCC) has been exploited through complex mathematical models to measure the impact of various histologic features of primary melanomas and of sentinel lymph node deposits and to correlate these parameters with patient survival. The wealth of modern information available to pathologists and clinicians has become of vital interest to the prognostication of the individual patient with melanoma. The purpose of this review is to bring to the attention of anatomic pathologists the essential characteristics of the pathology report for primary cutaneous melanoma in the modern era.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446717     DOI: 10.1038/modpathol.3800517

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  18 in total

1.  Melanoma histopathology report: proposal for a standardized terminology.

Authors:  Anna Batistatou; Ozay Gököz; Martin G Cook; Daniela Massi
Journal:  Virchows Arch       Date:  2010-12-31       Impact factor: 4.064

2.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

Review 3.  Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Authors:  Ross L Pearlman; Mary Katherine Montes de Oca; Harish Chandra Pal; Farrukh Afaq
Journal:  Cancer Lett       Date:  2017-01-25       Impact factor: 8.679

4.  Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.

Authors:  T Krenacs; G Kiszner; E Stelkovics; P Balla; I Teleki; I Nemeth; E Varga; I Korom; T Barbai; V Plotar; J Timar; E Raso
Journal:  Histochem Cell Biol       Date:  2012-06-12       Impact factor: 4.304

Review 5.  Tumors of the hand.

Authors:  Andreas F Mavrogenis; Georgios N Panagopoulos; Andrea Angelini; Jan Lesenský; Christos Vottis; Panayiotis D Megaloikonomos; Zinon T Kokkalis; Vasilios Kontogeorgakos; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

6.  Correlation of cell cycle regulatory proteins (p53 and p16(ink)⁴(a)) and bcl-2 oncoprotein with mitotic index and thickness of primary cutaneous malignant melanoma.

Authors:  Miloš Kostov; Zaklina Mijović; Dragan Mihailović; Snežana Cerović; Miroslav Stojanović; Marija Jelić
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

7.  Nuclear stiffening inhibits migration of invasive melanoma cells.

Authors:  Alexandre J S Ribeiro; Payal Khanna; Aishwarya Sukumar; Cheng Dong; Kris Noel Dahl
Journal:  Cell Mol Bioeng       Date:  2014-12-01       Impact factor: 2.321

Review 8.  [Epithelioid and hyperpigmented melanocytic tumors. An overview].

Authors:  H Kutzner; L Schärer; L Requena
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

9.  Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images.

Authors:  Joel Saltz; Rajarsi Gupta; Le Hou; Tahsin Kurc; Pankaj Singh; Vu Nguyen; Dimitris Samaras; Kenneth R Shroyer; Tianhao Zhao; Rebecca Batiste; John Van Arnam; Ilya Shmulevich; Arvind U K Rao; Alexander J Lazar; Ashish Sharma; Vésteinn Thorsson
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.423

10.  Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.

Authors:  G E Piérard
Journal:  ISRN Dermatol       Date:  2012-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.